Erdő-Bonyár, Szabina and Rapp, Judit and Subicz, Rovéna and Filipánits, Kristóf and Minier, Tünde and Kumánovics, Gábor and Czirják, László and Berki, Tímea and Simon, Diána (2024) Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25 (14). ISSN 1661-6596
|
Text
ijms-25-07933.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Type I interferon (IFN-I) signaling has been shown to be upregulated in systemic sclerosis (SSc). Dysregulated B-cell functions, including antigen presentation, as well as antibody and cytokine production, all of which may be affected by IFN-I signaling, play an important role in the pathogenesis of the disease. We investigated the IFN-I signature in 71 patients with the more severe form of the disease, diffuse cutaneous SSc (dcSSc), and 33 healthy controls (HCs). Activation via Toll-like receptors (TLRs) can influence the IFN-I signaling cascade; thus, we analyzed the effects of the TLR homologue CD180 ligation on the IFN-I signature in B cells. CD180 stimulation augmented the phosphorylation of signal transducer and activator of transcription 1 (STAT1) in dcSSc B cells (p = 0.0123). The expression of IFN-I receptor (IFNAR1) in non-switched memory B cells producing natural autoantibodies was elevated in dcSSc (p = 0.0109), which was enhanced following anti-CD180 antibody treatment (p = 0.0125). Autoantibodies to IFN-Is (IFN-alpha and omega) correlated (dcSSc p = 0.0003, HC p = 0.0192) and were present at similar levels in B cells from dcSSc and HC, suggesting their regulatory role as natural autoantibodies. It can be concluded that factors other than IFN-alpha may contribute to the elevated IFN-I signature of dcSSc B cells, and one possible candidate is B-cell activation via CD180.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | CD180; Toll-like receptor; B cells; interferon (IFN); signal transducer and activator of transcription 1; IFN-I receptor; anti-IFN-α autoantibodies; anti-IFN-ω autoantibodies; systemic sclerosis |
Subjects: | R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában |
SWORD Depositor: | MTMT SWORD |
Depositing User: | MTMT SWORD |
Date Deposited: | 24 Sep 2024 09:06 |
Last Modified: | 24 Sep 2024 09:06 |
URI: | https://real.mtak.hu/id/eprint/205674 |
Actions (login required)
![]() |
Edit Item |